InflammoPharmacology
Anti-inflammatory properties and pharmacological induction of Hsp70 after brain injury
Chemical genetics of neuroinflammation: natural and synthetic compounds as microglial inhibitors
Effects of antidepressants and cyclooxygenase-2 inhibitor on cytokines and kynurenines in stimulated in vitro blood culture from depressed patients
Inflammation in neurological and psychiatric diseases
New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates—Nrf2 activators and GSK-3 inhibitors
NSAIDs in the treatment and/or prevention of neurological disorders
The role of inflammatory processes in Alzheimer’s disease